Jocelyn Lim Chua

In 2006, the United States Department of Defense for the first time authorized the use of FDA-approved psychiatric medications in the physical and tactical spaces of military operations, including active combat. This policy change overturned a century of military psychiatry orthodoxy, which prioritized non-pathologizing, non-medication treatment for combat stress. Amid an ongoing global war, the US military embraced psychopharmacy as...